News &
Events
CORPORATE ANNOUNCEMENTS & PORTFOLIO UPDATES
Stay informed on the latest product launches, regulatory milestones, corporate activities and strategic partnerships from Solaris Pharma Corporation.
News
Featured Article
June 22, 2026
Solaris Launches Generic Briviact
Solaris has announced the launch of brivaracetam tablets, a generic version of UCB’s branded epilepsy medication Briviact.
The tablets are approved for managing partial-onset seizures in patients as young as 1 month old — a condition that impacts millions of people each year.
The generic is offered in five strengths — 10mg, 25mg, 50mg, 75mg, and 100mg — and comes in 60-count bottles.
This release marks a significant step for
Solaris Pharma Receives FDA Approval for First Generic Clindamycin Phosphate Topical Gel, 1%
August 23, 2021
BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) — Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the Company